Abstract
Abstract
Background
Our aim was to determine the association between diet quality and depression incidence in the population-based REGICOR cohort study, Catalonia, Spain.
Methods
Prospective observational study using participants’ baseline (2003–2006), follow-up (2007–2013) and clinical records data. Five diet quality scores were derived from a food frequency questionnaire (FFQ) at baseline: the relative Mediterranean Diet Score (rMED), the Modified Mediterranean Diet Score (ModMDS), a Dietary Approaches to Stop Hypertension (DASH) score, a Healthful Plant-based Diet Index (HPDI) and the World Health Organization Healthy Diet Indicator (WHO-HDI). Participants using pharmacological antidepressant treatment were excluded as a proxy for presence of depression at baseline. At follow-up, the Patient Health Questionnaire (PHQ-9) was applied to assess depressive symptoms (≥ 10 defining depressive disorder). A secondary outcome was depression diagnosis assessed through clinical records. Logistic regression and Cox proportional hazards models were used.
Results
Main analysis included 3046 adults (50.3% women) with a mean age of 54.7 (SD = 11.6) years. After 6-years follow-up, 184 (6.04%) cases of depressive disorder were identified. There was 16% lower odds of depressive disorder per 1SD increase of rMED (OR = 0.84; 95%CI = 0.71–0.98). Secondary outcome analysis (n = 4789) identified 261 (5.45%) incident cases of clinical depression diagnosis over 12 years follow-up, and 19% lower risk of clinical depression was observed with the WHO-HDI (HR = 0.81; 95%CI = 0.70–0.93). Adjusting for BMI did not attenuate the findings.
Conclusions
A significant inverse association between diet quality and depression incidence was found in this population-based cohort study, independent of sociodemographic, health and lifestyle. Adherence to a healthy diet could be a complementary intervention for the prevention of depression.
Funder
‘la Caixa’ Foundation
Agència de Gestió d'Ajuts Universitaris i de Recerca
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. GBD 2019 Mental Disorders Collaborators (2022) Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Psychiatry 9(2):137–150
2. Encuesta de salud de Catalunya. El estado de salud, los comportamientos relacionados con la salud y el uso de servicios sanitarios en Cataluña (2020) Resumen ejecutivo de los principales resultados de la ESCA del 2020. Dirección General de Planificación en Salud. Generalitat de Cataluña. Enero 2022. Available in: https://salutweb.gencat.cat/ca/el_departament/estadistiques_sanitaries/enquestes/esca/resultats_enquesta_salut_catalunya/
3. Köhler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, Bortolato B, Melo MCA, Coelho CA, Fernandes BS, Olfson M, Ioannidis JPA, Carvalho AF (2018) Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and mendelian randomization studies. J Psychiatr Res 103:189–207
4. Ruberto VL, Jha MK, Murrough JW (2020) Pharmacological treatments for patients with treatment-resistant depression. Pharmaceuticals (Basel) 13(6):116
5. Sansone RA, Sansone LA (2012) Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci 9:41